We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+6.15%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$33.3B
AUM Growth
+$2.6B
Cap. Flow
+$811M
Cap. Flow %
2.43%
Top 10 Hldgs %
54.46%
Holding
2,177
New
190
Increased
747
Reduced
824
Closed
175

Sector Composition

Rank Sector Weight
1 Technology 4.75%
2 Financials 4.71%
3 Healthcare 1.93%
4 Communication Services 1.71%
5 Consumer Discretionary 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFM
1776
Aberdeen Municipal Income Fund
MFM
$222M
$79K ﹤0.01%
11,117
-750
-6% -$5.28K
CTIC
1777
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$79K ﹤0.01%
50,073
CVS icon
1778
CALL
CVS Health
CVS
$137B
$78K ﹤0.01%
6,000
+3,000
+100% +$211K
SPPI
1779
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$77K ﹤0.01%
+21,031
New +$170K
NE
1780
DELISTED
Noble Corporation
NE
$77K ﹤0.01%
63,279
+1,787
+3% +$2.14K
ADMS
1781
DELISTED
Adamas Pharmaceuticals
ADMS
$76K ﹤0.01%
20,000
VG
1782
DELISTED
Vonage Holdings Corporation
VG
$75K ﹤0.01%
+10,100
New +$87.3K
OCUL icon
1783
Ocular Therapeutix
OCUL
$1.86B
$74K ﹤0.01%
18,713
+2,313
+14% +$8.04K
NBRV
1784
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$74K ﹤0.01%
224
BCIC
1785
BCP Investment Corp
BCIC
$86.9M
$73K ﹤0.01%
3,424
+977
+40% +$21.1K
GGN
1786
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$767M
$72K ﹤0.01%
+16,278
New +$69.4K
LULU icon
1787
CALL
lululemon athletica
LULU
$13B
$72K ﹤0.01%
1,400
-3,100
-69% -$661K
VNRX icon
1788
VolitionRx Ltd
VNRX
$12M
$72K ﹤0.01%
760
PPT
1789
Franklin Premier Income Trust
PPT
$323M
$71K ﹤0.01%
13,143
-800
-6% -$4.3K
GFI icon
1790
Gold Fields
GFI
$29.2B
$70K ﹤0.01%
+10,605
New +$60.1K
BABA icon
1791
CALL
Alibaba
BABA
$269B
$67K ﹤0.01%
+21,100
New +$3.96M
MMT
1792
Aberdeen Multi-Market Income Fund
MMT
$237M
$67K ﹤0.01%
10,931
-630
-5% -$3.8K
KGC icon
1793
Kinross Gold
KGC
$28.5B
$65K ﹤0.01%
13,609
-20,032
-60% -$90.4K
OGI
1794
Organigram Holdings
OGI
$132M
$65K ﹤0.01%
6,681
-413
-6% -$4.88K
OVID icon
1795
Ovid Therapeutics
OVID
$435M
$64K ﹤0.01%
15,532
+600
+4% +$1.9K
AIH
1796
DELISTED
Aesthetic Medical International Holdings
AIH
$64K ﹤0.01%
+10,000
New +$72.3K
EEM icon
1797
PUT
iShares MSCI Emerging Markets ETF
EEM
$28B
$63K ﹤0.01%
+31,200
New +$1.34M
IBRX icon
1798
ImmunityBio
IBRX
$7.44B
$63K ﹤0.01%
16,714
VRTX icon
1799
CALL
Vertex Pharmaceuticals
VRTX
$121B
$63K ﹤0.01%
+800
New +$162K
ATRS
1800
DELISTED
Antares Pharma, Inc.
ATRS
$63K ﹤0.01%
13,500

Similar funds

Creative Planning's Q4 2019 Portfolio in Review

As of Q4 2019, Creative Planning held 2,177 positions worth $33.3B, up 8.5% from $30.7B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Creative Planning's Q4 2019 filing shows 190 new, 747 increased, 824 reduced and 175 closed positions. Its largest new stake was CrowdStrike: 673,132 shares worth $8.39M. The largest sale was Vanguard Mid-Cap ETF, an estimated $76.8M.

By sector, the portfolio is most concentrated in Technology at 4.7% of assets, up from 4.1% a quarter earlier, followed by Financials and Healthcare.

  • Creative Planning's largest Q4 2019 buy was CrowdStrike: 673,132 shares worth $8.39M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q4 2019, an estimated $178M increase.
  • Creative Planning's biggest Q4 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $76.8M.
  • Creative Planning fully exited Buckeye Partners, L.P. in Q4 2019, selling an estimated $25.7M.
  • Creative Planning's ten largest holdings make up 54% of its $33.3B portfolio in Q4 2019.
  • Creative Planning opened 190 new positions and closed 175 in Q4 2019.
  • Creative Planning's portfolio value rose 8.5% quarter-over-quarter to $33.3B.

Based on Creative Planning's 13F filing for Q4 2019, filed 30 Jan 2020.